BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8466163)

  • 1. Elevated levels of maternal serum inhibin immunoreactivity in second trimester pregnancies affected by Down's syndrome.
    Spencer K; Wood PJ; Anthony FW
    Ann Clin Biochem; 1993 Mar; 30 ( Pt 2)():219-20. PubMed ID: 8466163
    [No Abstract]   [Full Text] [Related]  

  • 2. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A.
    Wallace EM; Swanston IA; McNeilly AS; Ashby JP; Blundell G; Calder AA; Groome NP
    Clin Endocrinol (Oxf); 1996 Jan; 44(1):17-21. PubMed ID: 8706288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal serum dimeric inhibin A in second-trimester Down's syndrome pregnancies.
    Cuckle HS; Holding S; Jones R; Wallace EM; Groome NP
    Prenat Diagn; 1995 Apr; 15(4):385-6. PubMed ID: 7617583
    [No Abstract]   [Full Text] [Related]  

  • 4. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
    Aitken DA; Wallace EM; Crossley JA; Swanston IA; van Pareren Y; van Maarle M; Groome NP; Macri JN; Connor JM
    N Engl J Med; 1996 May; 334(19):1231-6. PubMed ID: 8606718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Second-trimester maternal serum immunoreactive inhibin as a marker for fetal Down's syndrome.
    Van Lith JM; Pratt JJ; Beekhuis JR; Mantingh A
    Prenat Diagn; 1992 Oct; 12(10):801-6. PubMed ID: 1475248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second trimester levels of maternal serum inhibin A, total inhibin, alpha inhibin precursor, and activin in Down's syndrome pregnancy.
    Lambert-Messerlian GM; Canick JA; Palomaki GE; Schneyer AL
    J Med Screen; 1996; 3(2):58-62. PubMed ID: 8849760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of maternal serum immunoreactive inhibin as a first trimester marker of Down's syndrome.
    Wallace EM; Harkness LM; Burns S; Liston WA
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):483-6. PubMed ID: 7955459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of maternal serum dimeric inhibin A as a first-trimester marker of Down's syndrome.
    Wallace EM; Grant VE; Swanston IA; Groome NP
    Prenat Diagn; 1995 Apr; 15(4):359-62. PubMed ID: 7617577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second trimester maternal serum ADAM12 levels in Down's syndrome pregnancies.
    Donalson K; Turner S; Wastell H; Cuckle H
    Prenat Diagn; 2008 Oct; 28(10):904-7. PubMed ID: 18785180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal serum inhibin levels in second-trimester Down's syndrome pregnancies.
    Cuckle HS; Holding S; Jones R
    Prenat Diagn; 1994 May; 14(5):387-90. PubMed ID: 7521963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A.
    Haddow JE; Palomaki GE; Knight GJ; Foster DL; Neveux LM
    J Med Screen; 1998; 5(3):115-9. PubMed ID: 9795869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of inhibin A and unconjugated oestriol in the second trimester of pregnancy.
    Brown LF; Shearing CH; Tydeman G
    Ann Clin Biochem; 2011 Jan; 48(Pt 1):72-4. PubMed ID: 21115569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical validation of a new dimeric inhibin-A assay suitable for second trimester Down's syndrome screening.
    Knight GJ; Palomaki GE; Neveux LM; Haddow JE; Lambert-Messerlian GM
    J Med Screen; 2001; 8(1):2-7. PubMed ID: 11373844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SURUSS in perspective.
    Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
    Semin Perinatol; 2005 Aug; 29(4):225-35. PubMed ID: 16104673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal serum inhibin-A in pregnancies complicated by insulin dependent diabetes mellitus.
    Wallace EM; Crossley JA; Ritoe SC; Groome NP; Aitken DA
    Br J Obstet Gynaecol; 1997 Aug; 104(8):946-8. PubMed ID: 9255088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second-trimester dimeric inhibin-A in Down's syndrome screening.
    Spencer K; Wallace EM; Ritoe S
    Prenat Diagn; 1996 Dec; 16(12):1101-10. PubMed ID: 8994245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated screening for Down's syndrome based on tests performed during the first and second trimesters.
    Wald NJ; Watt HC; Hackshaw AK
    N Engl J Med; 1999 Aug; 341(7):461-7. PubMed ID: 10441601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of smoking status on inhibin-A in second-trimester prenatal screening for Down syndrome.
    Huttly W; Bestwick J; Wald N
    Prenat Diagn; 2014 Apr; 34(4):406-7. PubMed ID: 24395085
    [No Abstract]   [Full Text] [Related]  

  • 19. [Evaluation of Down's syndrome screening methods using maternal serum biochemistry in the second trimester pregnancy].
    Yu DY; Fu P; Zhang ZH; Wang F; Han MY; Ren HY; Zhao W; Zhang K; Li S; Jiang N
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Jun; 28(3):332-5. PubMed ID: 21644235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First-trimester or second-trimester screening, or both, for Down's syndrome.
    Malone FD; Canick JA; Ball RH; Nyberg DA; Comstock CH; Bukowski R; Berkowitz RL; Gross SJ; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Dukes K; Bianchi DW; Rudnicka AR; Hackshaw AK; Lambert-Messerlian G; Wald NJ; D'Alton ME;
    N Engl J Med; 2005 Nov; 353(19):2001-11. PubMed ID: 16282175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.